Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Sell
10,800
-600
-5% -$97.5K 0.01% 356
2025
Q4
$2.22M Buy
11,400
+8,300
+268% +$1.98M 0.01% 302
2025
Q3
$872K Buy
3,100
+100
+3% +$25.5K 0.01% 380
2025
Q2
$656K Buy
+3,000
New +$484K 0.01% 345

Other funds holding ORCL

Marex Group's ORCL Position: Q1 2026 in Review

Marex Group reduced its Oracle (ORCL) stake by 24% in Q1 2026, selling an estimated $37.9M and leaving 749,887 shares worth $110M. The position accounts for 0.7% of the portfolio, ranked #37.

Marex Group first reported a position in ORCL in Q4 2022 and has held it in 11 quarters since. The position peaked at $192M in Q4 2025. 3,472 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Marex Group held 749,887 shares of Oracle worth $110M as of Q1 2026.
  • Marex Group sold 232,899 Oracle shares in Q1 2026, an estimated $37.9M.
  • Oracle made up 0.7% of Marex Group's portfolio in Q1 2026, its #37 holding.
  • Marex Group first reported a position in Oracle in Q4 2022 and has held it in 11 quarters since.
  • Marex Group's Oracle position peaked at $192M in Q4 2025.
  • 3,472 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.